Verastem Inc

Financials

Activos totales 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Total de pasivos 39.08 M21.1 M47.66 M71.19 M130.43 M189.25 M Capital total 115.27 M87.56 M47.39 M57.37 M-28.89 M57.2 M Total de pasivos y patrimonio neto 154.35 M108.66 M95.05 M149.72 M101.54 M246.44 M Deuda total 19.05 M249 K24.8 M40.09 M40.72 M76.33 M Deuda neta -144.01 M-97.12 M-61.11 M-95.57 M-46.55 M-128.13 M

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem Inc

Noticias

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

H.C. Wainwright reitera calificación de acciones de Verastem por datos duraderos del ensayo

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

Verastem mantiene calificación de Compra en BTIG tras datos duraderos del ensayo

La combinación de fármacos contra el cáncer de Verastem muestra durabilidad en datos de dos años

Jefferies reduce el precio objetivo de Verastem tras actualización de valoración

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)

BTIG inicia cobertura de Verastem con recomendación de Compra y precio objetivo de 19 dólares

BTIG inicia cobertura de Verastem con recomendación de Compra y precio objetivo de $19

Verastem stock initiated at Buy by BTIG with $19 price target

Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?